Investors

<p>Close up of a middle aged woman dressed in a blazer, sitting down while looking at another person in the foreground.</p>

Welcome to Mendus’ Investor Relations page. Mendus is listed on NASDAQ Stockholm under the ticker symbol IMMU. You will find all relevant information on the Mendus share in our Investors section.

Events & Presentations

    2023

    2023

    Upcoming

    AACR Annual Meeting 2023

    Mendus to present positive interim data from the ALISON trial in ovarian cancer at the AACR Annual Meeting. Members of Mendus' leadership team and Business Development team will participate.
    Learn more
    Upcoming

    Innovation for Health 2023

    CEO Erik Manting will participate.
    Learn more
    Upcoming

    8th Annual Innate Killer Summit

    Erik Manting, CEO of Mendus, will give a presentation and update on Mendus’ novel method for the expansion of memory NK cells.
    Learn more
    Previous

    BIO-Europe Spring 2023

    Members of Mendus’ leadership team will participate.
    Learn more
    Previous

    EQT Life Sciences’ BioCapital Europe

    Erik Manting, CEO of Mendus, will attend the conference.
    Learn more
    Previous

    Redeye Theme: Regenerative Medicine / Cell Therapy

    Mendus CEO Erik Manting will present and participate in an on-site Q&A session on February 22nd, 2023.
    Learn more
    Previous

    12th Annual LifeSci Partners Corporate Access Event

    Members of Mendus’ leadership team and Business Development team will be in San Francisco during the JPM Annual Healthcare Meeting 2023.
    Learn more